Literature DB >> 19744496

I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.

Daniel M Johnson1, Jordi Heijman, Chris E Pollard, Jean-Pierre Valentin, Harry J G M Crijns, Najah Abi-Gerges, Paul G A Volders.   

Abstract

In vivo studies have suggested that increased beat-to-beat variability of ventricular repolarization duration (BVR) is a better predictor of drug-induced torsades de pointes than repolarization prolongation alone. Cellular BVR and its dynamics before proarrhythmic events are poorly understood. We investigated differential responses of BVR in single myocytes during I(Ks) blockade versus I(Kr) blockade and late-I(Na) augmentation, under the influence of beta-adrenergic receptor stimulation. Transmembrane action potentials were recorded from isolated canine left-ventricular midmyocytes at various pacing rates. I(Ks) was blocked by HMR1556, I(Kr) by dofetilide. Late I(Na) was augmented by sea anemone toxin-II. Isoproterenol was added for beta-adrenergic receptor stimulation. BAPTA-AM buffered intracellular Ca(2+). SEA0400 partially inhibited the Na(+)-Ca(2+) exchanger. BVR was quantified as variability of action-potential duration at 90% repolarization: Sigma(|APD90; i+1 minus APD90; i|)/[nbeatsx radical2] for 30 consecutive action potentials. Baseline BVR was significantly increased by I(Kr) blockade and late-I(Na) augmentation, especially at slow pacing rates. beta-adrenergic stimulation restabilized these BVR changes. In contrast, I(Ks) blockade caused very little change in repolarization when compared to baseline conditions, but predisposed the myocyte to increased BVR during beta-adrenergic stimulation, especially at fast rates. BAPTA-AM and SEA0400 reduced this excessive BVR and eliminated early afterdepolarizations. In conclusion, beta-adrenergic receptor stimulation exaggerates BVR during I(Ks) blockade, indicating a BVR-stabilizing role of beta-adrenergic-sensitive I(Ks). Loss of I(Ks) plus overriding of Ca(2+)-dependent membrane currents, including inward Na(+)-Ca(2)(+) exchange current, conspire to proarrhythmic BVR under these conditions. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744496     DOI: 10.1016/j.yjmcc.2009.08.033

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  24 in total

1.  A multiscale investigation of repolarization variability and its role in cardiac arrhythmogenesis.

Authors:  Esther Pueyo; Alberto Corrias; László Virág; Norbert Jost; Tamás Szél; András Varró; Norbert Szentandrássy; Péter P Nánási; Kevin Burrage; Blanca Rodríguez
Journal:  Biophys J       Date:  2011-12-20       Impact factor: 4.033

2.  Ca2+-activated Cl- current is antiarrhythmic by reducing both spatial and temporal heterogeneity of cardiac repolarization.

Authors:  Bence Hegyi; Balázs Horváth; Krisztina Váczi; Mónika Gönczi; Kornél Kistamás; Ferenc Ruzsnavszky; Roland Veress; Leighton T Izu; Ye Chen-Izu; Tamás Bányász; János Magyar; László Csernoch; Péter P Nánási; Norbert Szentandrássy
Journal:  J Mol Cell Cardiol       Date:  2017-06-29       Impact factor: 5.000

3.  Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes.

Authors:  Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Balázs Horváth; Ferenc Ruzsnavszky; Krisztina Váczi; János Magyar; Tamás Bányász; András Varró; Péter P Nánási
Journal:  Pflugers Arch       Date:  2014-08-02       Impact factor: 3.657

4.  Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.

Authors:  Lin Wu; Jihua Ma; Hong Li; Chao Wang; Eleonora Grandi; Peihua Zhang; Antao Luo; Donald M Bers; John C Shryock; Luiz Belardinelli
Journal:  Circulation       Date:  2011-04-11       Impact factor: 29.690

5.  Autonomic and Cardiac Repolarization Lability in Long QT Syndrome Patients.

Authors:  Natalia DeMaria; Ahmed Selmi; Samuel Kashtan; Xiaojuan Xia; Matthew Wang; Wojciech Zareba; Jean-Philippe Couderc; David S Auerbach
Journal:  Auton Neurosci       Date:  2020-09-06       Impact factor: 3.145

6.  Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.

Authors:  L Nalos; R Varkevisser; M K B Jonsson; M J C Houtman; J D Beekman; R van der Nagel; M B Thomsen; G Duker; P Sartipy; T P de Boer; M Peschar; M B Rook; T A B van Veen; M A G van der Heyden; M A Vos
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 7.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

8.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

9.  Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab.

Authors:  Claudia Altomare; Alessandra Maria Lodrini; Giuseppina Milano; Vanessa Biemmi; Edoardo Lazzarini; Sara Bolis; Nicolò Pernigoni; Eleonora Torre; Martina Arici; Mara Ferrandi; Lucio Barile; Marcella Rocchetti; Giuseppe Vassalli
Journal:  Front Physiol       Date:  2021-04-07       Impact factor: 4.566

10.  Determinants of beat-to-beat variability of repolarization duration in the canine ventricular myocyte: a computational analysis.

Authors:  Jordi Heijman; Antonio Zaza; Daniel M Johnson; Yoram Rudy; Ralf L M Peeters; Paul G A Volders; Ronald L Westra
Journal:  PLoS Comput Biol       Date:  2013-08-22       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.